SPY311.41-4.77 -1.51%
DIA255.99-4.73 -1.81%
IXIC10,404.45-88.05 -0.84%

Goldman Sachs Initiates Coverage On Portola Pharmaceuticals with Neutral Rating

Goldman Sachs initiates coverage on Portola Pharmaceuticals (NASDAQ:PTLA) with a Neutral rating.

Benzinga · -

Goldman Sachs initiates coverage on Portola Pharmaceuticals (NASDAQ:PTLA) with a Neutral rating.